A Culturally Specific End-of-life Communication Skills Training
Effects of a Culturally Specific End-of-life Communication Skills Training for Chinese Oncology Nurses
1 other identifier
interventional
148
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate the effectiveness of culturally specific end-of-life communication skills training (CST) among Chinese oncology nurses. The main question it aims to answer is: What is the effectiveness of culturally specific end-of-life CST among Chinese oncology nurses? Participants will receive an 8-week communication skills training. Researchers will compare the intervention group and the wait-list group to see if skills, self-efficacy, and outcome expectancy beliefs will be improved.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 9, 2023
CompletedFirst Posted
Study publicly available on registry
June 5, 2023
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedFebruary 28, 2024
February 1, 2024
1.1 years
February 9, 2023
February 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline Skills at 3 months
Measured by Nurses' Clinic Communication Competency Scale, a 58-item self-reported scale which measures six dimensions. A 5-point Likert scale from (1) very poor to (5) very good is used. Higher scores mean a better outcome.
up to 3 months
Secondary Outcomes (2)
Change from Baseline Self-efficacy at 3 months
up to 3 months
Change from Baseline Outcome expectancy beliefs 3 months
up to 3 months
Other Outcomes (1)
Acceptance and satisfaction
up to 3 months
Study Arms (2)
Intervention group (IG)
EXPERIMENTALThe IG will receive the end-of-life CST between the two measurement points
Control group (CG)
OTHERThe CG will be a waitlist group and receive the training after the end of data collection.
Interventions
Training methods include lectures, video demonstrations, and simulation in small groups (4-5 trainees per group with multidisciplinary roles). Written and audiovisual learning materials will be offered. Each session will be 150 minutes, including lectures and video demonstration (90 min/session) and simulation and feedback (60 min/session). One session will be conducted in two weeks. Totally there will be four sessions completed in 8 weeks.
Routine training activities arranged by relevant departments in hospitals
Eligibility Criteria
You may qualify if:
- Registered nurses who work with advanced cancer patients in hospital settings
- Consent to participate in the study
You may not qualify if:
- Nurses working temporarily in the two hospitals as scholars or trainees from other hospitals
- Specialized nurses in palliative care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, 310000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joyce Chung, PhD
The Hong Kong Polytechnic University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, School of Nursing
Study Record Dates
First Submitted
February 9, 2023
First Posted
June 5, 2023
Study Start
September 1, 2023
Primary Completion
October 1, 2024
Study Completion
December 1, 2024
Last Updated
February 28, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share